Healthcare Commercialization Strategy
Find the expensive mistakes while they are still inexpensive to correct.
Early-stage healthcare companies often commit serious time and capital around untested assumptions about the customer, buyer, payment pathway, market entry, evidence requirements, and route to revenue.Craig Long helps founders challenge those assumptions before they become embedded, and build a clearer pathway to sustainable, resilient revenue.Get the free report: Seven Expensive Mistakes Early-Stage Healthcare Companies Make on the Pathway to Revenue.
IN U.S. Healthcare, Alignment is everything
Promising healthcare products, services, and treatments are often delayed, overlooked, or abandoned because critical business assumptions remain unresolved.
Healthcare companies rarely fail for one single reason. More often, a series of reasonable-sounding assumptions gradually leads the company in the wrong direction.The person using the product may not be the person buying it.The organization benefiting from it may not control the budget.Clinical value may not create a viable payment pathway.Regulatory clearance may permit market entry without creating market demand.A successful pilot may prove that the product works without proving that anyone will purchase it at scale.And an attractive total market may conceal a first market that is slow, expensive, or nearly impossible to enter.These problems are cheapest to correct before the company has hired around them, built around them, raised capital around them, or promised them to investors.
Before you build
Start with the seven mistakes that cost healthcare companies the most.
Seven Expensive Mistakes Early-Stage Healthcare Companies Make on the Pathway to RevenueThis practical executive report examines the commercial assumptions that repeatedly cost healthcare companies time, capital, momentum, and investor confidence.You will learn:Why clinical need does not automatically create a viable market
How the user, buyer, beneficiary, and payer can be different parties
Why regulatory strategy is only one part of commercialization
How companies choose the wrong first market
Why interest and positive feedback are not the same as customer validation
How premature spending can embed a flawed business model
What investors need to see beyond a promising product[Download the Free Executive Report]
The Healthcare Pathway to Revenue Review
Before you spend the next $250,000, examine the assumptions beneath it.
The Pathway to Revenue ReviewBefore committing more capital, hiring around an untested model, or presenting unresolved assumptions to investors, take an independent look at the business beneath the product.The Pathway to Revenue Review is a focused assessment for early-stage healthcare companies preparing to build, raise capital, enter the market, begin a pilot, or choose their first customer segment.We examine the assumptions most likely to determine whether the company reaches sustainable, resilient revenue:Who uses, buys, benefits, and pays
Whether the proposed customer has the authority and motivation to act
The business model, payment pathway, and first market
Evidence, regulatory, and operational requirements
Commercial sequencing and where capital may be committed too early
What You Receive
Review of your pitch deck and key commercial materials
A 90-minute strategic working session with Craig Long
Written findings identifying the most consequential risks and unresolved assumptions
Prioritized recommendations for the next 90 days
One follow-up call to clarify the findings
Clear Findings in 10 Business DaysYour written review will be delivered within 10 business days after payment, completion of the intake questionnaire, receipt of requested materials, and the working session.Fixed Fee: $2,500This is a defined assessment with a clear scope, timeline, and deliverable, not the beginning of an open-ended consulting engagement.No one can guarantee the success of an early-stage company. Better information, clearer priorities, and fewer preventable mistakes can materially improve the odds.
decades of results
Craig A Long
Craig is a healthcare executive, operator, strategist, and entrepreneur with more than three decades of experience leading organizations, evaluating business models, solving operational problems, and helping companies navigate complex healthcare markets.His experience spans executive leadership, healthcare operations, commercialization strategy, organizational growth, and contracting, with organizations ranging from Fortune 500 companies and global NGOs to early-stage startups working with limited resources.Too many valuable healthcare products and services never reach their potential because the path from a strong solution to a viable business is more complex than it first appears, particularly in the U.S. healthcare market. Craig’s goal is to identify those companies early, uncover the gaps, and give them a stronger chance at success.That stronger chance begins with a clear understanding of who buys, who pays, what evidence the market requires, how the company should enter, and what must be true for revenue to become both sustainable and resilient.Craig provides independent healthcare commercialization reviews through Care Access LLC.
Before the Next Check Gets Written
Find the problems before the market finds them for you.
Before committing your next major block of capital, hiring around an untested model, or presenting unresolved assumptions to investors, take an independent look at the business beneath the product.
© 2026 Care Access LLC. All rights reserved.Services are provided by Craig Long through Care Access LLC.The Pathway to Revenue Review provides strategic business analysis and does not constitute legal, regulatory, clinical, accounting, reimbursement, securities, or investment advice. Results and business success cannot be guaranteed.
